Bavarian Nordic INC.

Biotechnology pharmaceutical product discovery and development.

Based in DC

🤖

AI Overview

With $1.6M in lobbying spend across 34 quarterly filings, Bavarian Nordic INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.

$1.6M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$180K
2019	$180K
2020	$180K
2021	$180K
2022	$270K
2023	$180K
2024	$225K
2025	$240K

Issues Lobbied

Health Issues

Lobbying Firms

East End Group, LLC

Lobbyists

Michael Woody Andrew Hawkins David Mohler Kelly Childress Lange

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

•General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and

•General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and

•The re-authorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.